Login or sign up
For business

OssiFi

4.0ยท 12 reviews
Average ratingGreat
4.0/ 5

Based on 12 reviews

533%
433%
333%
20%
10%
Ask AI

Ask AI about OssiFi

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Jeremy Manalansan
Reviews 1

OssiFi is a trustworthy company. Their services are excellent, and the website is easy to navigate. The rates are competitive, and the customer support team is always available to assist. I have been a customer for a while now, and I am very satisfied with their service. Highly recommended!

Celia Vieira
Reviews 1

I am a customer of OssiFi, and I must say their services are excellent. The website is easy to navigate, and the rates are competitive. The customer support team is always available to assist. I highly recommend OssiFi to anyone looking for financial services. ๐Ÿ˜ƒ

Andy Price
Reviews 1

I am a customer of OssiFi and I must say their services are excellent. The website is easy to navigate and the customer support is always available to assist. The rates are competitive and the overall experience has been great. I highly recommend OssiFi to anyone looking for financial services.

Veronica Van Dyke
Reviews 1

I am a happy customer of OssiFi. Their services are excellent, and the website is easy to navigate. The rates are competitive, and the customer support team is always available to assist. I highly recommend OssiFi to anyone looking for financial services.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About OssiFi

OssiFi is focused on developing the next generation of bone graft substitutes to stimulate fracture repair, reduce the rate of delayed or non-unions and accelerate return to function. Unlike orthobiologic competitors, OssiFi utilizes a proprietary small molecule to modulate bone growth through Sclerostin inhibition. Its carrier matrix is intended to combine excellent handling characteristics, ideal release kinetics and cellular in-growth capabilities with demonstrated biocompatibility. The company plans to conduct rigorous scientific and clinical studies to prove superior efficacy and safety over standard of care. This evidence, which is lacking in competitive biomaterials, will ultimately drive their commercial success and support the best patient care possible.

Website
ossifi.com